The store will not work correctly when cookies are disabled.
2-Nitro-3-(4-nitrophenyl)amino-3-oxopropionitrile potassium salt
ID: ALA1651807
PubChem CID: 90660744
Max Phase: Preclinical
Molecular Formula: C9H5KN4O5
Molecular Weight: 249.16
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N#CC(C(=O)Nc1ccc([N+](=O)[O-])cc1)=[N+]([O-])[O-].[K+]
Standard InChI: InChI=1S/C9H5N4O5.K/c10-5-8(13(17)18)9(14)11-6-1-3-7(4-2-6)12(15)16;/h1-4H,(H-,11,14,17,18);/q-1;+1
Standard InChI Key: KNPXAVKOUYDEEO-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 18 0 0 0 0 0 0 0 0999 V2000
12.5312 -22.7187 0.0000 K 0 0 0 0 0 15 0 0 0 0 0 0
16.3140 -19.9008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3128 -20.7276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0272 -21.1403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7433 -20.7272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7404 -19.8971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0254 -19.4882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5984 -21.1394 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8847 -20.7265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1704 -21.1379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8853 -19.9020 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.3905 -20.8676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1533 -21.9622 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6087 -20.5974 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8616 -22.3911 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4338 -22.3615 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.4551 -19.4808 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.4520 -18.6563 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.1706 -19.8904 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9 10 1 0
5 6 1 0
9 11 2 0
3 4 1 0
6 7 2 0
10 12 1 0
13 10 2 0
7 2 1 0
12 14 3 0
2 3 2 0
3 8 1 0
13 15 1 0
13 16 1 0
4 5 2 0
8 9 1 0
17 18 2 0
17 19 1 0
6 17 1 0
M CHG 6 1 1 13 1 15 -1 16 -1 17 1 19 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 249.16 | Molecular Weight (Monoisotopic): 249.0265 | AlogP: 0.51 | #Rotatable Bonds: 3 |
Polar Surface Area: 145.16 | Molecular Species: ACID | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: -6.89 | CX Basic pKa: 1.50 | CX LogP: -1.78 | CX LogD: -2.03 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.36 | Np Likeness Score: -1.53 |
References
1. Giorgis M, Lolli ML, Rolando B, Rao A, Tosco P, Chaurasia S, Marabello D, Fruttero R, Gasco A.. (2011) 1,2,5-Oxadiazole analogues of leflunomide and related compounds., 46 (1): [PMID:21109332] [10.1016/j.ejmech.2010.10.029] |